glutathione push and a phosphatidylcholine iv pusg High-Dose Add-On GPX4 in the Tumor Microenvironment:

Epub 2015 Dec 14 Martinelli-Boneschi F, Colombi M, Castori M, Devigili G, Eleopra R, Malik RA, Ritelli M, Zoppi N, Dordoni C, Sorosina M, Grammatico P, Fadavi H, Gerrits MM, Almomani R, Faber CG, Merkies IS, Toniolo D, Network INGI, Cocca M, Doglioni C, Waxman SG, Dib-Hajj SD, Taiana MM, Sassone J, Lombardi R, Cazzato D, Zauli A, Santoro S, Marchi M, Lauria G

Laftavi MR, Weber-Shrikant E, Kohli R, Patel S, Feng L, Said M, Dayton M, Pankewycz O (2010) Sirolimus-induced isometric tubular vacuolization: a new sirolimus histopathologic manifestation

Jomova K, Makova M, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, Rhodes CJ, Valko M (2022) Essential metals in health and disease

Xie J, Gong L, Zhu S, Yong Y, Gu Z, Zhao Y

These include a relatively redox/ferroptosis-resistant background, a narrow dosing window, and the presence of a rescuable conformational p53 mutation

The deregulated expression of miR-125b, miR-205, and miR-424 is shown to be adequate in inducing resistance to aromatase inhibitors (AIs), activating the AKT/mTOR pathway, and triggering the emergence of a subset of cells exhibiting stem-like characteristics